Azeliragon

MedChem Express

Azeliragon [603148-36-3]

10

603148-36-3

Research Use Only

99.37

C32H38ClN3O2

532.12

Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimers disease (AD) [1] . Azeliragon also can cross the blood-brain barrier (BBB) [2] .

ClC1=CC=C(C=C1)OC2=CC=C(C=C2)N3C(CCCC)=NC(C(C=C4)=CC=C4OCCCN(CC)CC)=C3

-20°C,2°C to 8°C

12352200